SVG Sprites

Press

Press Releases 08.05.2020

Release: HHS Feels Heat on Vaccine Development Conflicts of Interest

WASHINGTON, D.C. – Public Citizen and Lower Drug Prices Now today filed two additional ethics complaints [here and here] regarding COVID-19 vaccine czar Dr. Moncef Slaoui, following an initial complaint to the U.S. Department of Health and Human Services (HHS) Office of the Inspector General (OIG) in May that resulted in no action.

Press Releases 08.05.2020

Statement on Moderna’s 100% taxpayer funded vaccine

“Moderna just admitted that its covid vaccine is 100% taxpayer-funded, only a week after comfortably stating before Congress that it plans to make a profit on a vaccine the American people have already paid nearly a billion dollars to develop. Moderna executives and insiders have already made $200 million off of the stock gains resulting from announcements of vaccine trials and government awards.”

Press Releases 07.31.2020

Statement on $2 billion in tax dollars granted to Sanofi and GSK

The Trump Administration’s Operation Warp Speed has just awarded $2.1 billion — a record amount of taxpayer money — to Sanofi and GSK, pharmaceutical companies working to develop a coronavirus vaccine. The head of Operation Warp Speed, Moncef Slaoui, holds $10 million of shares in GSK. Lower Drug Prices Now has filed an ethics complaint for how the Trump Administration has used a loophole to exempt Slaoui from disclosure rules.

Press Releases 07.28.2020

Statement on Moderna’s extra $472 million from taxpayers

On Sunday, Reuters reported that Operation Warp Speed candidate Moderna received an additional $472 million in funding from BARDA to develop its potential COVID vaccine. Following the announcement, Moderna saw shares increase 11.3% in premarket trading on Monday. US taxpayers total funding for the experimental vaccine of Moderna is now $955 million.

Press Releases 07.24.2020

Statement on President Trump’s Executive Orders on drug pricing

These Executive Orders are not about policy, they’re about politics. The only reason for President Trump’s rekindled interest in lowering drug prices is his dwindling poll numbers, and realization that our country’s senior citizens are abandoning him thanks to his bungled handling of the coronavirus crisis.

Press Releases 07.22.2020

Statement on Pfizer receiving $2 billion from taxpayers for COVID vaccine

Statement from Margarida Jorge, campaign director for Lower Drug Prices Now, on news that U.S. will pay $2 billion for Pfizer/BioNTech coronavirus vaccine doses.

Press Releases 07.21.2020

Statement on drug executive testimony to House Energy & Commerce Committee

“Drug corporations are masterful at marketing. They recognize the current race for a COVID vaccine as a fantastic opportunity for free PR to redeem some of their tarnished brands. We expect in today’s subcommittee hearing that officials from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer will show up to position their companies as good-faith philanthropists wanting to save the day with a COVID vaccine. But the public knows there’s only one thing that motivates Big Pharma: more profits.”

Thank You for standing with us to put people before Pharma Profits!

Join our campaign, endorse our principles